Truffle Capital is a leading independent European private equity firm originally set up for investing in technology spin-offs.
Truffle Capital invests exclusively in Energy, Information Technologies, and Life Sciences companies throughout Europe. The firm is led by a team of four General Partners with decades of successful investment and entrepreneurial experience in Europe and Silicon Valley. They are business-builders who bring a hands-on approach to turning portfolio companies into technology and market leaders.
|MyoPowers Medical Technologies||7/11||Series B||$16M||3|
|Immune Targeting Systems||3/10||Series A||$13.2M||4|
|Cytomics Pharmaceuticals||2/06||Series B||€10M||3|
|RF-iT Solutions||1/06||Series A||$4.89M||2|